Literature DB >> 6244737

Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes.

S A Huber, L P Job, J F Woodruff.   

Abstract

Spleen cells from male adult BALB/c mice given intraperitoneal injections of purified coxsackievirus B-3 were examined for the ability to lyse syngeneic neonatal myofibers in culture. Cytotoxicity against infected and uninfected targets was measured with the use of an in vitro 51Cr release assay. Immune spleen cells obtained 4--7 days after infection were cytotoxic for viral-infected myofibers. Peak reactivity was observed 5 days after infection. At this time immune spleen cells showed significantly less reactivity against uninfected myofibers. Cytotoxicity against infected targets was mediated by T lymphocytes, since reactivity was abolished by treatment with anti-thy 1.2 and complement. Treatment with anti-Ig and complement caused no loss of activity. Reciprocal assays performed with BALB/c and CBA cells showed that maximal cytotoxicity occurred against infected syngeneic myofibers, providing further evidence that viral-specific effector cells were T lymphocytes. In addition, hyperimmune rabbit anti-coxsackievirus B-3 antiserum could not block immune spleen cell lysis of infected targets, suggesting that coxsackievirus-infected myofibers expressed surface membrane antigens not recognized by specific neutralizing antibody.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244737      PMCID: PMC1903528     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Myocarditis in experimental Coxsackie B-3 infection.

Authors:  E I GRODUMS; G DEMPSTER
Journal:  Can J Microbiol       Date:  1959-12       Impact factor: 2.419

2.  Limited persistence of viral antigen in coxsackievirus B3 induced heart disease in mice.

Authors:  T G Roesing; B J Landau; R L Crowell
Journal:  Proc Soc Exp Biol Med       Date:  1979-03

3.  Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue.

Authors:  R E Paque; C J Gauntt; T J Nealon; M D Trousdale
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

4.  Mechanism of immunologically specific killing of tumour cells by macrophages.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1972-03-24       Impact factor: 49.962

5.  Replication of poliovirus RNA studied by gel filtration and electrophoresis.

Authors:  B Oberg; L Philipson
Journal:  Eur J Biochem       Date:  1969-12

Review 6.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

Review 7.  The cytopathology of enteroviral infection.

Authors:  G C Godman
Journal:  Int Rev Exp Pathol       Date:  1966

Review 8.  Adult heart disease due to the Coxsackie virus B infection.

Authors:  G S Sainani; E Krompotic; S J Slodki
Journal:  Medicine (Baltimore)       Date:  1968-03       Impact factor: 1.889

9.  Coxsackie B myopericarditis in adults.

Authors:  W G Smith
Journal:  Am Heart J       Date:  1970-07       Impact factor: 4.749

10.  Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.

Authors:  C Y Wong; J J Woodruff; J F Woodruff
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

View more
  37 in total

Review 1.  Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis.

Authors:  M W Cunningham
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.

Authors:  E K Godeny; C J Gauntt
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

Review 3.  Immune modulation of cardiac cell function.

Authors:  G F Schreiner
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

Review 4.  Role of cytotoxic T cells in experimental myocarditis.

Authors:  N Van Houten; S A Huber
Journal:  Springer Semin Immunopathol       Date:  1989

5.  Cytotoxic T lymphocytes and natural killer cell activity in the course of mengo virus infection of mice.

Authors:  D Hassin; R Fixler; H Bank; A S Klein; Y Hasin
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

Review 6.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

Review 7.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

8.  Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.

Authors:  C J Gauntt; R E Paque; M D Trousdale; R J Gudvangen; D T Barr; G J Lipotich; T J Nealon; P S Duffey
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies.

Authors:  Adita Mascaro-Blanco; Kathy Alvarez; Xichun Yu; JoAnn Lindenfeld; Leann Olansky; Timothy Lyons; David Duvall; Janet S Heuser; Albina Gosmanova; Carl J Rubenstein; Leslie T Cooper; David C Kem; Madeleine W Cunningham
Journal:  Autoimmunity       Date:  2008-09       Impact factor: 2.815

10.  Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway.

Authors:  Christopher C Kemball; Stephanie Harkins; Jason K Whitmire; Claudia T Flynn; Ralph Feuer; J Lindsay Whitton
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.